Oxygen Gas
FDA Label NDC 52003-011

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Messer Canada Inc. for the product Oxygen (NDC 52003-011). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warnings and precautions section, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings And Precautions Section

Should the material not be delivered to a USP customer, the material is “Not Approved for Human Drug Use.”

Package Label.Principal Display Panel

 

Linde

Certicate of Analysis - Oxygen USP

Product: Oxygen USP

Date

 

Facility Name

 

Facility Address

 

Lot#

 

Batch #

 

Final Analysis Results

Analyzer #

Test/Units

USP Specs

Analysis Results

N/A

Odor

None

 

 

% O2

> 99.0%
(Linde Spec >99.50%)

  %

 

ppm H2O

N/A

  ppm

 

ppm THC

N/A

  ppm

N/A

% CO

≤ .001

  ***

N/A

% CO2

≤ .03

  ***

NT= not tested

*** = This product was manufactured by Air Liquefaction and testing is exempt under the USP compendium.

The methodology used to perform the USP test:

     Paramagnetic Analyzer Manufacturer / Model# : _______________________________________________

This analyzer has been validated by Linde as acceptable alternatives to the official USP for Oxygen Assay.  Validation study documentation is maintained at the Linde Corporate Offices.

Analyst

Date

 

 

 

 

Quality Reviewer

Date

 

 

 

 

 

Should the material not be delivered to a USP customer, the material is “Not Approved for Human Drug Use.”

2.4 October 2017

ASU-22-06-GAM-Medical Gas Procedures

Page 1 of 1

Retention Period – 3 Years

Copyright © The Linde Group – Distributed by a locally registered Linde Company

* Please review the disclaimer below.